Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine Concentration and Nerve Block Duration
NCT03326609Phase 4Completed
- Sponsor
- Nordsjællands Hospital
- Start
- Oct 2017
- Primary completion
- Dec 2017
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in pain, sponsored by Nordsjællands Hospital. Started Oct 2017; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
pain
Beyond the preview
Go deeper on NCT03326609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03326609.